65 related articles for article (PubMed ID: 18096481)
1. Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.
Maurer JR; Ryu J; Beck G; Moss J; Lee JC; Finlay G; Brown K; Chapman J; McMahan J; Olson E; Ruoss S; Sherer S;
J Heart Lung Transplant; 2007 Dec; 26(12):1293-9. PubMed ID: 18096481
[TBL] [Abstract][Full Text] [Related]
2. Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis.
Palipana AK; Gecili E; Song S; Johnson SR; Szczesniak RD; Gupta N
Chest; 2023 Jun; 163(6):1458-1470. PubMed ID: 36610667
[TBL] [Abstract][Full Text] [Related]
3. Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study.
Sakurai T; Kanou T; Funaki S; Fukui E; Kimura T; Ose N; Inoue Y; Shintani Y
Respir Investig; 2024 Jul; 62(4):657-662. PubMed ID: 38761480
[TBL] [Abstract][Full Text] [Related]
4. Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.
Hirose M; Matsumuro A; Arai T; Sugimoto C; Akira M; Kitaichi M; Young LR; McCormack FX; Inoue Y
PLoS One; 2019; 14(2):e0212776. PubMed ID: 30818375
[TBL] [Abstract][Full Text] [Related]
5. Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion.
Esposito AJ; Imani J; Shrestha S; Bagwe S; Lamattina AM; Vivero M; Goldberg HJ; Rosas IO; Henske EP; El-Chemaly SY
J Bras Pneumol; 2023; 49(2):e20220356. PubMed ID: 37132737
[TBL] [Abstract][Full Text] [Related]
6. Childhood interstitial lung disease in Turkey: first data from the national registry.
Nayır-Büyükşahin H; Emiralioğlu N; Kılınç AA; Girit S; Yalçın E; Şişmanlar Eyüboğlu T; Çobanoğlu N; Cinel G; Pekcan S; Gökdemir Y; Oğuz B; Orhan D; Doğru D; Özçelik U; Başkan AK; Arslan H; Çokuğraş H; Onay ZR; Oksay SC; Tortop DM; Aslan AT; Kekeç H; Zirek F; Tekin MN; Gülen F; Girgin Dindar B; Eryılmaz Polat S; Uytun S; Yılmaz Aİ; Ünal G; Eralp EE; Karadağ B; Hangül M; Köse M; Özsezen B; Çakır E; Bingöl A; Hızal M; Kartal Öztürk G; Uyan ZS; Ramaslı Gürsoy T; Serbes M; Kiper N
Eur J Pediatr; 2024 Jan; 183(1):295-304. PubMed ID: 37875631
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts.
Taveira-DaSilva AM; Johnson SR; Julien-Williams P; Johnson J; Stylianou M; Moss J
Thorax; 2020 Oct; 75(10):904-907. PubMed ID: 32788260
[TBL] [Abstract][Full Text] [Related]
8. Lymphangioleiomyomatosis and tuberous sclerosis complex.
Chorianopoulos D; Stratakos G
Lung; 2008; 186(4):197-207. PubMed ID: 18408969
[TBL] [Abstract][Full Text] [Related]
9. Lymphangioleiomyomatosis: a clinical update.
McCormack FX
Chest; 2008 Feb; 133(2):507-16. PubMed ID: 18252917
[TBL] [Abstract][Full Text] [Related]
10. Lymphangioleiomyomatosis and pregnancy: a mini-review.
Zhou J; Diao M
Arch Gynecol Obstet; 2024 Jun; 309(6):2339-2346. PubMed ID: 38594407
[TBL] [Abstract][Full Text] [Related]
11. Tuberous sclerosis complex for the pulmonologist.
Rebaine Y; Nasser M; Girerd B; Leroux C; Cottin V
Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34348978
[TBL] [Abstract][Full Text] [Related]
12. Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited.
Abdelwahab EMM; Bovari-Biri J; Smuk G; Fillinger J; McPhail D; Krymskaya VP; Pongracz JE
Apoptosis; 2021 Jun; 26(5-6):253-260. PubMed ID: 33860865
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes.
Zhang J; Liu D; Yue B; Ban L; Zhou M; Wang H; Lv J; Wu B; Zhai Z; Xu KF; Chen W; Chen J
Front Med (Lausanne); 2021; 8():584826. PubMed ID: 33665195
[No Abstract] [Full Text] [Related]
14. Pregnancy unmasking symptoms of undiagnosed lymphangioleiomyomatosis: Case report and review of literature.
Khaddour K; Shayuk M; Ludhwani D; Gowda S; Ward WL
Respir Med Case Rep; 2019; 26():63-67. PubMed ID: 30555778
[TBL] [Abstract][Full Text] [Related]
15. Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective.
Bassi I; Hollis G; Cottin V; Harari S; Zwanenburg E; Veltkamp M; Casanova A; Fletcher M; Masefield S; Powell P; Boyd J
ERJ Open Res; 2016 Apr; 2(2):. PubMed ID: 27730199
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation.
Zaki KS; Aryan Z; Mehta AC; Akindipe O; Budev M
World J Transplant; 2016 Mar; 6(1):249-54. PubMed ID: 27011924
[TBL] [Abstract][Full Text] [Related]
17. Multiple cystic lung disease.
Ferreira Francisco FA; Soares Souza A; Zanetti G; Marchiori E
Eur Respir Rev; 2015 Dec; 24(138):552-64. PubMed ID: 26621970
[TBL] [Abstract][Full Text] [Related]
18. Management of lymphangioleiomyomatosis.
Taveira-DaSilva AM; Moss J
F1000Prime Rep; 2014; 6():116. PubMed ID: 25580270
[TBL] [Abstract][Full Text] [Related]
19. Diffuse cystic lung diseases.
Ryu JH; Tian X; Baqir M; Xu K
Front Med; 2013 Sep; 7(3):316-27. PubMed ID: 23666611
[TBL] [Abstract][Full Text] [Related]
20. Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
Neurohr C; Hoffmann AL; Huppmann P; Herrera VA; Ihle F; Leuschner S; von Wulffen W; Meis T; Baezner C; Leuchte H; Baumgartner R; Zimmermann G; Behr J
Respir Res; 2011 May; 12(1):66. PubMed ID: 21600034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
